List of Groups
This is a world-wide list of patient groups supporting those patients and families affected with Chronic Myeloid Leukemia (CML). If your group not listed here, please register. If details have changed, please contact us.
Or click on the map to have an interactive, fast glance:
UK: CMLSupport
Last Updated on Friday, 09 November 2012 16:28 | 
Contact details
CML Support UKPO Box 56213
London N4 4WF
United Kingdom.
Web: http://www.cmlsupport.org.uk
E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Contact Persons
Sandy Craine.Organisation Profile
This site is published and maintained by CML patients and carers, for the use of CML patients, their families and carers. Our aim is to provide support and updated information regarding the best available therapy for CML patients in the UK and Europe, although we warmly welcome membership from all CML patients worldwide.We have no medical qualifications and the information contained on this site is not intended to replace expert medical advice that you may be given.
We do our best to ensure that any information we publish is accurate and strongly advise that any decisions about your treatment should be made after discussions with your haematologist or other suitably qualified medical professional.
We are independent of and not affiliated to any pharmaceutical company, medical institution or professional organisation.
We are a registered Charity, with a Board of 3 Trustees.
Subscribe
RSS
-
Generics
-
Scientific Literature on Generics and Copies
-
Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers (Clin Ther. 2009)
-
Failure of a non-authorized copy product to maintain response achieved with imatinib in a patient with chronic phase chronic myeloid leukemia: a case report.
-
Failure of copy Imatib (CIPLA, India) to maintain hematologic and cytogenetic responses in chronic myeloid leukemia in chronic phase (Int J Hematol. 2010
-
